RECRUITING

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Official Title

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome

Quick Facts

Study Start:2016-10
Study Completion:2027-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02848274

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Tatiana Neal
CONTACT
650-709-7838
tatianan@stanford.edu

Principal Investigator

Youn H Kim, MD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

City of Hope
Duarte, California, 91010
United States
Stanford University, School of Medicine
Palo Alto, California, 94305
United States
University of Iowa
Iowa City, Iowa, 52242
United States
Hackensack University Medical Center
Hackensack, New Jersey, 07601
United States
University of Pittsburg
Pittsburgh, Pennsylvania, 15260
United States
University of Texas Southwestern
Dallas, Texas, 75390
United States
University of Utah Hospital
Salt Lake City, Utah, 84132
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Youn H Kim, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-10
Study Completion Date2027-03

Study Record Updates

Study Start Date2016-10
Study Completion Date2027-03

Terms related to this study

Additional Relevant MeSH Terms

  • Mycosis Fungoides
  • Non-Hodgkin's Lymphoma